Medicines Gaps Study

Status Recruiting

Clinical Trial Summary

The adherence project aims to understand adherence rates and barriers to Direct oral anticoagulants (DOACs) and statins and improve awareness of healthcare professionals on adherence across Leeds. During the first component of the project, the investigation of rates of non-adherence was classed as service evaluation. The second component of this project, which this IRAS application refers to, will look into patient perspectives and barriers to adherence. Currently, such information is not routinely collected and only requested as part of shorter or longer consultations depending on a pre-defined clinical agenda and with little attention to adherence. Two specific questionnaires have been designed and integrated within the primary care medical records systems. Following invitation for target patients on DOACs and/or statins to respond anonymously, responses to the questionnaire(s) will be stored in their medical records. Data will then be extracted from the two systems [SystmOne and Egton Medical Information Systems (EMIS)] using unique system identifiers, that will be pseudonymised at the time of extraction. All patient pseudonymised information (including medical records system identifiers and responses to the questionnaire) will be extracted by the LTHT Researcher-Pharmacist following access provided by each participating General Practitioner (GP) Practice, based on searches built centrally by the Data Quality Team of the Leeds Clinical Commissioning Group (CCG). Apart from the dissemination of findings based on the questionnaire, a training package for health professionals will be designed and delivered. The aim of the training is to combine and disseminate all findings of the project, raise awareness on real-world non-adherence prevalence and the common barriers to adherence, demonstrate the usefulness of routine adherence estimation and suggest tools to address non-adherence in daily practice. The objectives of this training will also consider the training needs of healthcare professionals locally, as per the healthcare professionals survey that has been designed and circulated.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05332158
Study type	Interventional
Source	The Leeds Teaching Hospitals NHS Trust
Contact	Emmanouela Kampouraki, PhD
Phone	0113 3926856
Email	mymedsurvey.lth@nhs.net
Status	Recruiting
Phase	N/A
Start date	May 30, 2022
Completion date	September 30, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05546931` - Mobile Health Program for Rural Hypertension	N/A
Recruiting	`NCT04316715` - Life-Steps Counseling to Enhance Adherence and Engagement in PrEP Care	N/A
Active, not recruiting	`NCT04602468` - Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER)	Phase 4
Active, not recruiting	`NCT04588883` - Strengthening Families Living With HIV in Kenya	N/A
Enrolling by invitation	`NCT04676204` - Relationship Between Oral DMT Burden and Adherence in MS
Not yet recruiting	`NCT03807388` - ReMindCare App for Patients From First Episode of Psychosis Unit.	N/A
Completed	`NCT05168449` - The Impact of Pharmacist-led Mobile Application on Adherence in Chronic Kidney Disease Patients	N/A
Active, not recruiting	`NCT04612088` - Intervention for Multivitamin Adherence on Bariatric Patients	N/A
Completed	`NCT03958331` - Behavioral Economics and Adherence in Teens (BEAT!)	N/A
Completed	`NCT05233644` - Medication Adherence in Heart Failure After Hospitalisation
Completed	`NCT03837496` - Small-group, Virtual Program for Improving Symptoms and Distress Related to Hormonal Therapy for Breast Cancer Survivors	N/A
Recruiting	`NCT03683966` - MigALastat Therapy Adherence Among FABRY Patients: A Prospective Multicentral Observational Study
Withdrawn	`NCT04754867` - Pre-Test of For the Future Self and Smoking Cessation	N/A
Recruiting	`NCT05996094` - Antiretroviral Adherence and Drug-level Monitoring
Not yet recruiting	`NCT06056037` - Making ART Work Among Brazilian Youth	N/A
Completed	`NCT03842436` - Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance Use	Phase 4
Completed	`NCT03651596` - Leveraging mHealth Messaging to Promote Adherence in Teens With CKD	N/A
Completed	`NCT03658252` - Efficacy of Targeted Intervention for Topical Steroid Phobia.	N/A
Completed	`NCT03081559` - Improving Engagement in HIV Care for High-risk Women	N/A
Recruiting	`NCT05515497` - BMT4me: Post-HSCT Medication Adherence mHealth App	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Medicines Gaps Study — MeGa

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms